伽玛刀放射外科治疗三叉神经痛的长期结果
本研究回顾性纳入103例接受伽玛刀放射外科治疗的药物难治性原发性三叉神经痛患者,随访至少10年(平均174个月),初始疼痛缓解率为82.5%,末次随访为58.2%,末次随访时24.3%出现感觉障碍(BNI麻木评分≥II),2.9%为非常困扰状态(BNI麻木评分IV)。作者认为长期疗效良好,短期至中期随访中令人担忧的严重并发症可自行缓解,因此应扩大治疗适应证以包括强烈希望接受伽玛刀治疗的患者。
要点
- 伽玛刀治疗药物难治性原发性三叉神经痛初始疼痛缓解率82.5%,末次随访降至58.2%。
- 末次随访时BNI麻木评分≥II者占24.3%,BNI麻木评分IV者占2.9%。
- 作者认为短期至中期随访中严重关注的并发症可自行缓解,应扩大适应证。
核心结论
- 伽玛刀放射外科治疗原发性三叉神经痛在长期随访中显示良好的治疗效果。
- 短期至中期随访中令人担忧的严重并发症可自行缓解。
- 作者认为治疗适应证应扩大至强烈希望接受伽玛刀治疗的患者。
研究设计与样本
- 回顾性研究,纳入2003年1月至2011年10月在本机构接受伽玛刀放射外科治疗的249例连续原发性三叉神经痛患者中的103例。
- 纳入标准为治疗后随访至少10年(平均174个月,范围120-219个月)且数据可准确评估。
- 伽玛刀靶点为三叉神经根后(retrogasserian),4 mm单等中心,100%处方剂量90 Gy。
- 采用Barrow神经病学研究所(BNI)疼痛强度量表评估疼痛,BNI麻木量表评估并发症(面部感觉异常)。
主要发现
- 初始随访疼痛发作停止(BNI疼痛强度评分I-IIIa)率为82.5%(103例中85例)。
- 末次随访疼痛发作停止(BNI疼痛强度评分I-IIIa)率为58.2%(103例中60例)。
- 末次随访时感觉障碍(BNI麻木评分≥II)见于24.3%(103例中25例)。
- 末次随访时非常困扰状态(BNI麻木评分IV)见于2.9%的病例。
临床怎么用
- 作者认为,对于强烈希望接受伽玛刀治疗的原发性三叉神经痛患者,可扩大治疗适应证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although the short- to medium-term efficacy of Gamma Knife therapy for drug-resistant essential trigeminal neuralgia has been reported, long-term evaluations are limited. We evaluated patient data obtained at least 10 years post-treatment and examined the significance of this treatment using new end points. METHODS: Among 249 consecutive patients with essential trigeminal neuralgia who were treated with Gamma Knife radiosurgery (retrogasserian target/4-mm single isocenter/90 Gy at 100%) at our institution between January 2003 and October 2011, 103 patients who were followed up for at least 10 years (mean, 174 [120-219] months) after treatment and whose data were amenable to accurate evaluation, were included in this retrospective study. Herein, we used the Barrow Neurological Institute (BNI) pain intensity scale as a clinical evaluation method for pain and the BNI numbness scale to evaluate complications (namely facial dysesthesia). RESULTS: The initial and final follow-up pain attack cessation (BNI pain intensity score I-IIIa) rate was 82.5% (85 of 103) and 58.2% (60 of 103), respectively. Furthermore, sensory impairment (BNI numbness score ≥ II) at the last follow-up was observed in 24.3% (25 of 103) of the cases, while very bothersome status (BNI numbness score IV) was observed in 2.9% of the cases. CONCLUSIONS: Gamma Knife radiosurgery for essential trigeminal neuralgia showed good therapeutic effects during long-term follow-up. Serious complications of significant concern in the short- to mid-term follow-up, resolved spontaneously. Therefore, the indications for treatment should be expanded to include patients who strongly desire Gamma Knife therapy.
引用
- Sato D, Hayashi M, Horiba A, et al. Long-Term Results of Gamma Knife Radiosurgery for Trigeminal Neuralgia. World Neurosurg. 2022. PMID: 36586580. doi:10.1016/j.wneu.2022.12.110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。